nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A glimpse into long COVID and symptoms
|
Yang, Chengliang |
|
|
10 |
9 |
p. e81 |
artikel |
2 |
A glimpse into long COVID and symptoms – Authors' reply
|
Huang, Lixue |
|
|
10 |
9 |
p. e82 |
artikel |
3 |
An online breathing and wellbeing programme (ENO Breathe) for people with persistent symptoms following COVID-19: a parallel-group, single-blind, randomised controlled trial
|
Philip, Keir E J |
|
|
10 |
9 |
p. 851-862 |
artikel |
4 |
Awakening sleep disordered breathing in Africa
|
Ozoh, Obianuju B |
|
|
10 |
9 |
p. 812-813 |
artikel |
5 |
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial
|
Wolfe, Cameron R |
|
|
10 |
9 |
p. 888-899 |
artikel |
6 |
Clinical impact of bacterial syndromic testing in pneumonia
|
Pickens, Chiagozie I |
|
|
10 |
9 |
p. 816-818 |
artikel |
7 |
Correction to Lancet Respir Med 2022; 10: 761–75
|
|
|
|
10 |
9 |
p. e85 |
artikel |
8 |
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial
|
Abhishek, Abhishek |
|
|
10 |
9 |
p. 840-850 |
artikel |
9 |
Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial
|
Darie, Andrei M |
|
|
10 |
9 |
p. 877-887 |
artikel |
10 |
Guidelines might help reduce the burden of asthma in African children
|
Makoni, Munyaradzi |
|
|
10 |
9 |
p. e83-e84 |
artikel |
11 |
Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study
|
Huang, Lixue |
|
|
10 |
9 |
p. 863-876 |
artikel |
12 |
Improving COVID-19 vaccine immunogenicity by interrupting methotrexate treatment
|
Sparks, Jeffrey A |
|
|
10 |
9 |
p. 813-815 |
artikel |
13 |
Interrupting methotrexate to improve immunity after COVID-19 booster vaccination: is it really worth it?
|
Jorda, Anselm |
|
|
10 |
9 |
p. e80 |
artikel |
14 |
Living with a hitertho unnamed disease in sub-Saharan Africa
|
Olivier, Honvo |
|
|
10 |
9 |
p. 827-828 |
artikel |
15 |
Multiplex bacterial PCR for antibiotic stewardship in pneumonia
|
Dudoignon, Emmanuel |
|
|
10 |
9 |
p. e78 |
artikel |
16 |
Multiplex bacterial PCR for antibiotic stewardship in pneumonia – Author's reply
|
Darie, Andrei M |
|
|
10 |
9 |
p. e79 |
artikel |
17 |
Opportunities for improved clinical trial designs in acute respiratory distress syndrome
|
Wick, Katherine D |
|
|
10 |
9 |
p. 916-924 |
artikel |
18 |
Patient experience with obstructive sleep apnoea
|
Jew, Michael |
|
|
10 |
9 |
p. 828-830 |
artikel |
19 |
Prevalence of sleep-disordered breathing in an African general population: The Benin Society and Sleep (BeSAS) study
|
Wachinou, Ablo Prudence |
|
|
10 |
9 |
p. 831-839 |
artikel |
20 |
Smoking and e-cigarette use: key variables in testing IgA-oriented intranasal vaccines
|
McGrath, Joshua J C |
|
|
10 |
9 |
p. 822-824 |
artikel |
21 |
Smoking, nicotine, and COVID-19
|
Grigg, Jonathan |
|
|
10 |
9 |
p. 818-819 |
artikel |
22 |
The low flyers: persistent airflow limitation in young adults
|
Polverino, Francesca |
|
|
10 |
9 |
p. 819-822 |
artikel |
23 |
The Philippine vape bill: how politics affects health
|
Solidum, Jea Giezl N |
|
|
10 |
9 |
p. e86 |
artikel |
24 |
Tobacco product use and the risks of SARS-CoV-2 infection and COVID-19: current understanding and recommendations for future research
|
Benowitz, Neal L |
|
|
10 |
9 |
p. 900-915 |
artikel |
25 |
Transcriptomics in the intensive care unit
|
McLean, Anthony S |
|
|
10 |
9 |
p. 824-826 |
artikel |
26 |
Treating COVID-19-related breathlessness with novel interventions
|
Daynes, Enya |
|
|
10 |
9 |
p. 815-816 |
artikel |
27 |
Vaping in adolescents and young adults: it's time to act
|
The Lancet Respiratory Medicine, |
|
|
10 |
9 |
p. 811 |
artikel |